AnalysisNews

PHVS today

$33.83-$0.35 (-1.02%)close Nov 12, 2026

Trend

DailyDowntrend (starting)

4 hourExpanding

1 hourLeaning Bearish

15 minSymmetric Triangle

5 minLeaning Bearish

Daily trend turns up above $43.25

Key levels

Resistance$38.13

Resistance$35.41

Support$33.80

Support$31.60

Latest news & SEC filings

SEC FilingPharvaris N.V. filed an insider trading report (Form 4)

EarningsPharvaris Posts Q3 2026 Results

EarningsPharvaris reports Q3 loss of $0.77 per share, beating $0.82 estimate

EarningsPharvaris posts quarterly loss of €0.67 per share

All PHVS news →

About Pharvaris

Pharvaris is a clinical-stage biopharmaceutical company developing oral therapies for hereditary angioedema (HAE). Its product candidates include IR and XR formulations. The company operates in the United States and Europe, targeting patients with HAE and healthcare providers.

Based on the company's 20-F filed Apr 2, 2026.

Nasdaq · Healthcare

Pharvaris N.V. (PHVS)

$33.83-0.35 (-1.02%)
WATCHLISTGrade: BRisk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
29.1530.5631.9633.3733.83Oct 12Oct 20Oct 28Nov 5
High34.55
Low33.00
Open33.59
Volume343K
Avg Vol612K
VWAP33.88
30d High34.78
30d Low27.74
30d Chg+8.46%

What Is the Price Target for PHVS?

SEPT Low Target

$42.00

SEPT Mid Target

$56.00

SEPT High Target

$79.00

Analyst Consensus

$56.00

Current: $34.00Upside: +64.7%Confidence: 85%Method: Analyst Consensus

Is PHVS a Buy or Sell Right Now?

55
Investability Score
WATCHLIST12-18 months
News summary · last 30 days
Nov 12NeutralEarningsInsider buy2 articles
Pharvaris N.V. (PHVS) closed at $33.83, up 0.71% on the day, trading between a low of $33.00 and a high of $34.55 on volume of 367,858 shares. The company filed an insider trading report (Form 4), though such filings are typically treated as noise unless they reflect significant insider activity. Separately, Pharvaris posted its Q3 2026 results, a medium-impact earnings event that could shape sentiment depending on the details of the release. With no clear directional catalyst from either item, the stock's modest gain suggests a neutral near-term signal.
Critical news
Nov 12HIGHEarnings: growth/beat

Thesis

    AI-Powered Trading Signals

    Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for PHVS.

    Start Free Trial →

    Is PHVS Overvalued or Undervalued?

    Valuation Verdict

    UNDERVALUED

    Methods Used

    Analyst Consensus

    Fair Value

    $56.00

    12

    Moat Score

    NONE

    1/9

    Piotroski Score

    29.7

    Altman Z-Score

    What Is Smart Money Doing with PHVS?

    Insider Signal

    SELLING

    0 buys / 10 sells (90d)

    Congress Signal

    NEUTRAL

    0 buys / 0 sells (90d)

    Institutional

    N/A

    Short Squeeze Risk

    MEDIUM

    Signal: NEUTRAL

    Recent Insider Activity

    NameTitleTypeSharesValueDate
    Monges VivianedirectorBuy11,969$96KSep 23, 2026
    Monges VivianedirectorSale11,969$396KSep 23, 2026
    Lu PengofficerBuy45,308$117KSep 22, 2026
    Schikan Johannes Gerardus Christiaan PetrusdirectorBuy800$16KSep 22, 2026
    Schikan Johannes Gerardus Christiaan PetrusdirectorSale800$29KSep 22, 2026
    Nassif David W.officerSale6,000$219KSep 21, 2026
    Nassif David W.officerSale500-Sep 21, 2026
    Bjork ElisabethdirectorBuy35,000$504KSep 17, 2026
    Bjork ElisabethdirectorBuy17,500$317KSep 17, 2026
    Bjork ElisabethdirectorSale52,500$2.0MSep 17, 2026

    Track Smart Money Across 4,000+ Stocks

    Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

    See All Smart Money Signals →

    PHVS Growth Story

    Revenue YoY

    N/A%

    3yr Revenue CAGR

    N/A%

    EPS Growth YoY

    -24.93%

    FCF Growth YoY

    -18.6%

    Revenue Trend

    UNKNOWN

    Dark Pool Trades for PHVS

    PREVIEW

    SEPT Investing tracks real-time dark pool institutional trades for PHVS, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

    TimePriceSizeValueSide
    21:00:06$33.831,100$$37KSELL
    21:00:06$33.832,800$$95KSELL
    20:58:03$33.811,090$$37KBUY
    20:33:26$34.011,000$$34KSELL
    20:18:21$34.061,000$$34KSELL

    5 dark pool trades shown · $$237K preview volume

    Real-time institutional flow, block trades, and net positioning

    See all dark pool activity

    Options Flow for PHVS

    PREVIEW

    SEPT Investing provides real-time options flow tracking for PHVS, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.

    TypeStrikeExpiryDTEPremiumSizeTrade
    CALL$55Dec 1836$$453SWEEP
    PUT$32.5Nov 208$$801SWEEP
    PUT$32.5Nov 208$$801SWEEP
    PUT$32.5Nov 208$$801SWEEP
    PUT$32.5Nov 208$$801SWEEP

    5 options trades shown · 20% calls

    Unusual activity, GEX levels, max pain, and dealer positioning

    See full options flow

    What Traders Are Saying About PHVS

    1 posts

    SEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for PHVS. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.

    J
    Javier14h ago

    PHVS filed an insider trading report (Form 4).

    11 views

    Join 3,500+ traders discussing PHVS in real-time

    Trade ideas, setups, dark pool alerts, and AI-powered analysis

    Join the discussion

    Full AI Research Report

    SEPT's Trading AI has generated a free, downloadable PDF research report for Pharvaris N.V. (PHVS) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

    Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (5 articles analyzed), and SEC filing intelligence...

    AI-Powered Trading Signals.

    Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

    Try SEPT Free for 7 Days →

    PHVS — frequently asked questions

    What is PHVS stock price today?

    Pharvaris N.V. (PHVS) is at $33.83, down 1.02% (-$0.35) at the Nov 12, 2026 close.

    Why is PHVS stock down today?

    Nov 12, 2026: Pharvaris N.V. (PHVS) closed at $33.83, up 0.71% on the day, trading between a low of $33.00 and a high of $34.55 on volume of 367,858 shares.

    What is the PHVS price target?

    The average analyst price target for PHVS is $56.00, ranging from $42 to $79, based on 10 analysts. Latest: B of A Securities upgrade on Oct 23, 2026.

    What do analysts rate PHVS?

    Analyst ratings for PHVS: 4 Buy, 16 Hold, 0 Sell — consensus Hold.

    Did PHVS beat earnings?

    PHVS last reported on Nov 11, 2026: EPS -$0.77 vs -$0.82 expected — a beat of 6.1%.

    Does PHVS pay a dividend?

    PHVS does not currently pay a dividend.

    What are PHVS support and resistance levels?

    Support: $33.80, $31.60, $29.83. Resistance: $35.41, $38.13, $43.25.

    What are insiders doing with PHVS?

    Insider activity: SELLING, 0 buys and 10 sells in the last 90 days.

    What is the latest news on PHVS?

    Nov 12, 2026: Pharvaris N.V. filed an insider trading report (Form 4) · Nov 12, 2026: Pharvaris Posts Q3 2026 Results · Nov 12, 2026: Pharvaris reports Q3 loss of $0.77 per share, beating $0.82 estimate